47th week of 2020 patent applcation highlights part 25 |
Patent application number | Title | Published |
20200361944 | FRAGMENT SYNTHESIS OF CYCLIC PEPTIDES | 2020-11-19 |
20200361945 | SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) | 2020-11-19 |
20200361946 | Selective Inhibitors Of Protein Arginine Methytransterase 5 (PRMT5) | 2020-11-19 |
20200361947 | BICYCLIC AND TRICYCLIC COMPOUNDS | 2020-11-19 |
20200361948 | NEK INHIBITORS AND METHODS OF USE | 2020-11-19 |
20200361949 | PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF | 2020-11-19 |
20200361950 | ATF3 INDUCTION COMPOUNDS | 2020-11-19 |
20200361951 | Polymorphism for Irinotecan Free Base | 2020-11-19 |
20200361952 | THIENOPYRIDINE DERIVATIVES CONTAINING UNSATURATED ALIPHATIC OLEFINIC BOND, PREPARATION METHOD AND USE THEREOF | 2020-11-19 |
20200361953 | PRODUCTION METHOD OF THIENOPYRIMIDINE DERIVATIVE | 2020-11-19 |
20200361954 | FIVE-MEMBERED NON AROMATIC RING-PYRIMIDINE HIV-1 REVERSE TRANSCRIPTASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USES THEREOF | 2020-11-19 |
20200361955 | ORGANIC SEMICONDUCTING COMPOUNDS | 2020-11-19 |
20200361956 | METHOD OF TREATMENT OF SYMPTOMS OF MENOPAUSE | 2020-11-19 |
20200361958 | PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUG THEREOF | 2020-11-19 |
20200361959 | THIAZOLO-PYRIMIDINE HIV-1 REVERSE TRANSCRIPTASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USES THEREOF | 2020-11-19 |
20200361960 | SULFUR-CONTAINING POLYCYCLIC-HYDROXYPYRIDONE CARBOXAMIDE ANALOG AGAINST HIV | 2020-11-19 |
20200361961 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | 2020-11-19 |
20200361962 | BETA-LACTAMASE INHIBITORS | 2020-11-19 |
20200361963 | PYRIDINAMINE-PYRIDONE AND PYRIMIDINAMINE-PYRIDONE COMPOUNDS | 2020-11-19 |
20200361964 | LESS CORROSIVE ORGANOBORON COMPOUNDS AS LUBRICANT ADDITIVES | 2020-11-19 |
20200361965 | ATMOSPHERIC MOISTURE HARVESTER | 2020-11-19 |
20200361966 | COMPOSITION FOR DEPOSITING SILICON-CONTAINING THIN FILM AND METHOD FOR PRODUCING SILICON-CONTAINING THIN FILM USING THE SAME | 2020-11-19 |
20200361967 | ORGANOSILICON COMPOUND AND RUBBER COMPOSITION COMPRISING THE SAME | 2020-11-19 |
20200361968 | PEROVSKITE COMPOUND AND PHOTOCONVERSION DEVICE USING THE SAME | 2020-11-19 |
20200361969 | GROUP 4 METAL ELEMENT-CONTAINING COMPOUNDS, METHOD OF PREPARING THE SAME, PRECURSOR COMPOSITIONS INCLUDING THE SAME FOR FORMING A FILM, AND METHOD OF FORMING A FILM USING THE SAME | 2020-11-19 |
20200361970 | METAL COMPOUNDS AND METHODS OF FABRICATING SEMICONDUCTOR DEVICES USING THE SAME | 2020-11-19 |
20200361971 | Composite Phosphorus Flame Retardant Comprising Cyclic Organophosphate With Multiple DOPO Moieties And Preparation Method Thereof | 2020-11-19 |
20200361972 | RHODAMINE TRIPLET STATE COMPLEX AND PREPARATION AND PHOTODYNAMIC THERAPY (PDT) STUDY THEREOF | 2020-11-19 |
20200361973 | COMBINATION PRODUCT COMPRISING DICYCLOPLATIN AND PREPARATION METHOD AND USE THEREOF | 2020-11-19 |
20200361974 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2020-11-19 |
20200361975 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2020-11-19 |
20200361976 | TWO-DIMENSIONAL STIMULI-RESPONSIVE COVALENT ORGANIC FRAMEWORKS WITH HIGH INTRINSIC CONDUCTIVITY | 2020-11-19 |
20200361977 | STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES | 2020-11-19 |
20200361978 | NON-CALORIC SWEETENER | 2020-11-19 |
20200361979 | RECOVERY OF STEVIOL GLYCOSIDES | 2020-11-19 |
20200361980 | 14-MEMBERED KETOLIDES AND METHODS OF THEIR PREPARATION AND USE | 2020-11-19 |
20200361981 | GLYCOSYLTRANSFERASE INHIBITORS FOR TREATMENT OF SOLID TUMORS | 2020-11-19 |
20200361982 | BROAD SPECTRUM VIRAL INHIBITOR | 2020-11-19 |
20200361983 | PROCESS FOR THE PREPARATION OF GALNAC OLIGONUCLEOTIDE CONJUGATES | 2020-11-19 |
20200361984 | CLICK BASED LIGATION | 2020-11-19 |
20200361985 | METHOD FOR PURIFYING A SULFATASE PROTEIN | 2020-11-19 |
20200361986 | Capture Purification Processes for Proteins Expressed in a Non-Mammalian System | 2020-11-19 |
20200361987 | DEUTERATED TETRAPEPTIDES THAT TARGET MITOCHONDRIA | 2020-11-19 |
20200361988 | MERTANSINE POLYPEPTIDE CONJUGATES | 2020-11-19 |
20200361989 | COMPOSITION FOR AUTOPHAGY INHIBITING IN CELL, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEOPLASTIC DISEASE OR INHIBITING ANTI-CANCER AGENTS RESISTANCE CONTAINING THE SAME | 2020-11-19 |
20200361990 | POLYPEPTIDE HAVING ANALGESIC ACTIVITY AND USE THEREOF | 2020-11-19 |
20200361991 | COMPOUNDS FOR SELECTIVE DISRUPTION OF PROTEIN-PROTEIN INTERACTIONS | 2020-11-19 |
20200361992 | CONJUGATED HEPCIDIN MIMETICS | 2020-11-19 |
20200361993 | BIOMIMETIC PEPTIDE AND BIODEGRADABLE DELIVERY PLATFORM FOR THE TREATMENT OF ANGIOGENESIS- AND LYMPHANGIOGENESIS-DEPENDENT DISEASES | 2020-11-19 |
20200361994 | PEPTIDE ANTIBIOTICS | 2020-11-19 |
20200361995 | APRATYRAMIDE THERAPEUTIC AGENTS AND METHODS OF TREATMENT | 2020-11-19 |
20200361996 | PEPTIDIC MACROMOLECULAR ASSEMBLIES | 2020-11-19 |
20200361997 | CONFORMATIONALLY STABILIZED RSV PRE-FUSION F PROTEINS | 2020-11-19 |
20200361998 | COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATORY RESPONSES | 2020-11-19 |
20200361999 | HEME SEQUESTING PEPTIDES AND USES THEREFOR | 2020-11-19 |
20200362000 | GLYCAN-BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS | 2020-11-19 |
20200362001 | MYOKINES FOR TREATING CELL PROLIFERATIVE AND METABOLIC DISEASES AND DISORDERS | 2020-11-19 |
20200362002 | PROCESS FOR PROVIDING PEGYLATED PROTEIN COMPOSITION | 2020-11-19 |
20200362003 | IL-22 Fc FUSION PROTEINS AND METHODS OF USE | 2020-11-19 |
20200362004 | HETERODIMERIC FC-FUSED CYTOKINE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | 2020-11-19 |
20200362005 | HETERODIMERIC FC-FUSED CYTOKINE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | 2020-11-19 |
20200362006 | ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION | 2020-11-19 |
20200362007 | Novel GLP-1 Analogues | 2020-11-19 |
20200362008 | Loss of Function mutations in KCNJ10 cause SeSAME, a human syndrome with sensory, neurological, and renal deficits | 2020-11-19 |
20200362009 | Novel Hybrid ActRIIB Ligand Trap Proteins for Treating Muscle Wasting Diseases | 2020-11-19 |
20200362010 | NEUROPILIN-1 SPECIFIC BINDING PEPTIDE, FUSION PROTEIN FUSED WITH SAME, AND USE THEREOF | 2020-11-19 |
20200362011 | COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS | 2020-11-19 |
20200362012 | Method of Redirecting T Cells to Treat HIV Infection | 2020-11-19 |
20200362013 | EXPRESSION SYSTEMS AND METHODS OF USE THEREOF | 2020-11-19 |
20200362014 | APPLICATIONS OF SOLUBLE PROTEIN BAFF IN B CELL IN-VITRO CULTURE AND PROLIFERATION | 2020-11-19 |
20200362015 | METHODS AND COMPOSITIONS USING KLOTHO VARIANT POLYPEPTIDES | 2020-11-19 |
20200362016 | Molecular Size of Elastin-Like Polypeptide Delivery System for Therapeutics Modulates Deposition in the Placenta | 2020-11-19 |
20200362017 | MIMETIC PEPTIDES DERIVED FROM COLLAGEN TYPE IV AND THEIR USE FOR TREATING ANGIOGENESIS- AND LYMPHANGIOGENESIS- DEPENDENT DISEASES | 2020-11-19 |
20200362018 | INHIBITORS OF THE 20S PROTEASOME | 2020-11-19 |
20200362019 | DYNAMIC HUMAN ANTIBODY LIGHT CHAIN LIBRARIES | 2020-11-19 |
20200362020 | COMPOSITION FOR PREVENTING AND TREATING SKIN DISEASE COMPRISING MATERIAL SPECIFICALLY BINDING TO VIMENTIN-DERIVED PEPTIDE | 2020-11-19 |
20200362021 | ANTI-APELIN ANTIBODIES AND USES THEREOF | 2020-11-19 |
20200362022 | METHODS AND COMPOSITIONS FOR THE GENERATION AND USE OF HUMANIZED CONFORMATION-SPECIFIC PHOSPHORYLATED TAU ANTIBODIES | 2020-11-19 |
20200362023 | LYOPHILIZED FORMULATION OF A MONOCLONAL ANTIBODY AGAINST TRANSTHYRETIN | 2020-11-19 |
20200362024 | BIOLOGICAL MATERIALS AND USES THEREOF | 2020-11-19 |
20200362025 | TL1A PATIENT SELECTION METHODS, SYSTEMS, AND DEVICES | 2020-11-19 |
20200362026 | ULTRA-POTENT NEUTRALIZATION OF CYTOKINES BY MULTISPECIFIC ANTIBODIES AND USES THEREOF | 2020-11-19 |
20200362027 | METHODS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN AN ENHANCED PATIENT POPULATION USING BENRALIZUMAB | 2020-11-19 |
20200362028 | ANTIBODIES AGAINST IL-1 BETA | 2020-11-19 |
20200362029 | BIPARATOPIC FR-ALPHA ANTIBODIES AND IMMUNOCONJUGATES | 2020-11-19 |
20200362030 | CAVEOLIN-1 ANTIBODY FOR USE IN TREATING BRAIN INFLAMMATION AND INJURY AND IMPROVING FUNCTIONAL RECOVERY | 2020-11-19 |
20200362031 | COMPOUNDS THAT MODULATE THE INTERACTION OF VISTA AND VSIG3 AND METHODS OF MAKING AND USING | 2020-11-19 |
20200362032 | ANTI-GPR20 ANTIBODY AND ANTI-GPR20 ANTIBODY-DRUG CONJUGATE | 2020-11-19 |
20200362033 | ANTI-CD147 ANTIBODY | 2020-11-19 |
20200362034 | IgG Fc Variants for Veterinary Use | 2020-11-19 |
20200362035 | COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CANINES AND METHODS OF USE | 2020-11-19 |
20200362036 | NOVEL COMBINATION AND USE OF ANTIBODIES | 2020-11-19 |
20200362037 | ANTI-LAG-3 ANTIBODIES AND METHODS OF USE THEREOF | 2020-11-19 |
20200362038 | ANTIBODY-MEDIATED DELIVERY OF CAS9 TO MAMMALIAN CELLS | 2020-11-19 |
20200362039 | CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD3, EPCAMXCD3, IGF-1RXCD3 OR FAPALPHAXCD3 BISPECIFIC SINGLE CHAIN ANTIBODY | 2020-11-19 |
20200362040 | PD-1/PD-L1 INHIBITORS FOR THE TREATMENT OF CANCER | 2020-11-19 |
20200362041 | ANTI-FLT-1 ANTIBODIES IN TREATING BRONCHOPULMONARY DYSPLASIA | 2020-11-19 |
20200362042 | METHODS FOR THE TREATMENT OF EPILEPSY | 2020-11-19 |
20200362043 | Humanized anti-CCR7 receptor antibodies | 2020-11-19 |
20200362044 | Methods of Treating Cytokine Storm Infections, Including COVID-19, By Inhibiting CCR5/CCL5 (RANTES) Interaction, and Compositions for Practicing the Same | 2020-11-19 |